跳至主要内容
临床试验/NCT05604365
NCT05604365已完成不适用

FearLess in Cognitively Intact Patients With Glioma

Virginia Commonwealth University2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2022年11月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Determine the acceptability of FearLess intervention- Attendance

研究概览

简要总结

This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient inclusion:
  • Confirmed glioma diagnosis (grade II-IV) via histopathology
  • Be a minimum of 2 weeks post surgical repair or biopsy (if applicable)
  • Elevated FCR [> 13 on Fear of Cancer Recurrence Inventory]
  • Primarily English speaking
  • Caregiver Inclusion:
  • Loved one, or non-paid care partner to a patient with a confirmed glioma diagnosis (grade II-IV) via histopathology
  • Elevated FCR [> 13 on Fear of Cancer Recurrence Inventory]
  • Primarily English speaking

排除标准

  • Cognitive impairment [< or equal to 31 on the Telephone Interview for Cognitive Status (TICS)]
  • Inability to attend virtual sessions (e.g. due to lack of stable internet connection, difficulty using technology)
  • Inability to understand and provide informed consent.
  • Inability to attend virtual sessions (e.g. due to lack of stable internet connection, difficulty using technology)
  • Inability to understand and provide informed consent.

结局指标

主要结局

Determine the acceptability of FearLess intervention- Attendance

时间窗: 12 Weeks

As evidenced by attendance rate at intervention sessions

Determine feasibility of FearLess recruitment

时间窗: 1 Day

As evidenced by the number of patients and caregivers that enroll in the trial

Determine the feasibility of FearLess intervention- Data collection procedures

时间窗: 12 Weeks

As evidenced by the number of participants that complete the baseline assessment, post-intervention assessment, and the exit interview

Determine the acceptability of FearLess intervention- Retention Rate

时间窗: 12 Weeks

As evidenced by the number of patients that complete follow-up measures

Determine the acceptability of FearLess intervention- Satisfaction

时间窗: 12 Weeks

As evidenced by the number of patients with a satisfaction rating greater than 7 on a 10 point scale

Determine the acceptability of FearLess intervention- Satisfaction- Recommendation

时间窗: 12 Weeks

As evidenced by the number of patients that recommend the intervention to others

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

FearLess in Cognitively Intact Patients With Glioma | 临床试验